These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22280496)

  • 1. Use of radioactive compounds and autoradiography to determine drug tissue distribution.
    Solon EG
    Chem Res Toxicol; 2012 Mar; 25(3):543-55. PubMed ID: 22280496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiography techniques and quantification of drug distribution.
    Solon EG
    Cell Tissue Res; 2015 Apr; 360(1):87-107. PubMed ID: 25604842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled absorption, distribution, metabolism, and excretion studies in drug development: why, when, and how?
    Penner N; Xu L; Prakash C
    Chem Res Toxicol; 2012 Mar; 25(3):513-31. PubMed ID: 22309195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of drug distribution images from whole-body thin tissue sections obtained using desorption electrospray ionization tandem mass spectrometry and autoradiography.
    Kertesz V; Van Berkel GJ; Vavrek M; Koeplinger KA; Schneider BB; Covey TR
    Anal Chem; 2008 Jul; 80(13):5168-77. PubMed ID: 18481874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive application of autoradiography in pharmacokinetic and metabolic studies for the development of new drugs.
    Shigematsu A; Motoji N; Hatori A; Satoh T
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):122-42. PubMed ID: 8577948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of radiolabeled compounds in drug metabolism and pharmacokinetic studies.
    Isin EM; Elmore CS; Nilsson GN; Thompson RA; Weidolf L
    Chem Res Toxicol; 2012 Mar; 25(3):532-42. PubMed ID: 22372867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative whole-body autoradiography in the pharmaceutical industry. Survey results on study design, methods, and regulatory compliance.
    Solon EG; Kraus L
    J Pharmacol Toxicol Methods; 2001; 46(2):73-81. PubMed ID: 12481844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution pattern of intravenous [(14)C] artesunate in rat tissues by quantitative whole-body autoradiography and tissue dissection techniques.
    Li Q; Xie L; Zhang J; Weina PJ
    J Pharm Biomed Anal; 2008 Nov; 48(3):876-84. PubMed ID: 18762400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body autoradiography in drug discovery.
    Solon EG; Balani SK; Lee FW
    Curr Drug Metab; 2002 Oct; 3(5):451-62. PubMed ID: 12369892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid extraction surface analysis mass spectrometry (LESA-MS) as a novel profiling tool for drug distribution and metabolism analysis: the terfenadine example.
    Eikel D; Vavrek M; Smith S; Bason C; Yeh S; Korfmacher WA; Henion JD
    Rapid Commun Mass Spectrom; 2011 Dec; 25(23):3587-96. PubMed ID: 22095508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of quantitative whole-body autoradiography (QWBA) and imaging mass spectrometry (IMS) by matrix-assisted laser desorption/ionization (MALDI) in the assessment of ocular distribution of drugs.
    Drexler DM; Tannehill-Gregg SH; Wang L; Brock BJ
    J Pharmacol Toxicol Methods; 2011; 63(2):205-8. PubMed ID: 21040797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiography: high-resolution molecular imaging in pharmaceutical discovery and development.
    Solon EG
    Expert Opin Drug Discov; 2007 Apr; 2(4):503-14. PubMed ID: 23484758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of whole-body autoradioluminography in drug discovery for the quantification of tritium-labeled drug candidates.
    Potchoiba MJ; Nocerini MR
    Drug Metab Dispos; 2004 Oct; 32(10):1190-8. PubMed ID: 15377642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural alert/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States.
    Stepan AF; Walker DP; Bauman J; Price DA; Baillie TA; Kalgutkar AS; Aleo MD
    Chem Res Toxicol; 2011 Sep; 24(9):1345-410. PubMed ID: 21702456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR
    Arzneimittelforschung; 2010; 60(12):731-48. PubMed ID: 21265465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative whole-body radioluminography-future strategy for balance and tissue distribution studies.
    d'Argy R; Sundwall A
    Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 2):S57-62. PubMed ID: 10806061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALDI imaging mass spectrometry: bridging biology and chemistry in drug development.
    Castellino S; Groseclose MR; Wagner D
    Bioanalysis; 2011 Nov; 3(21):2427-41. PubMed ID: 22074284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development.
    Solon EG; Schweitzer A; Stoeckli M; Prideaux B
    AAPS J; 2010 Mar; 12(1):11-26. PubMed ID: 19921438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human radiolabeled mass balance studies: objectives, utilities and limitations.
    Penner N; Klunk LJ; Prakash C
    Biopharm Drug Dispos; 2009 May; 30(4):185-203. PubMed ID: 19544285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.